Attached files
| file | filename |
|---|---|
| 10-Q - Innovation Pharmaceuticals Inc. | form10q.htm |
| EX-31.1 - Innovation Pharmaceuticals Inc. | exh_31-1.htm |
| EX-32.1 - Innovation Pharmaceuticals Inc. | exh_32-1.htm |
Exhibit 10-35
ADDENDUM TO EHRLICH DEMAND UNSECURED NOTE
KNOWN AS EHRLICH PROMISSORY NOTE C
IN THE AMOUNT OF $1,750,000.00
DATED AUGUST 25, 2010
Today April 1, 2011, Cellceutix Corporation (“Cellceutix”) and Leo Ehrlich agree to amend the Ehrlich Promissory Note C as follows:
|
1.
|
The limit on the note is herewith changed to $2,000,000.
|
|
2.
|
Cellceutix agrees to convert accrued interest of $96,677 through December 31, 2010 into principal. This will result in the Ehrlich Promissory Note having a principal balance of $1,672,264 as of January 1, 2011.
|
|
3.
|
All other terms remain and are not changed.
|
_____/s/ Leo Ehrlich
Leo Ehrlich
______/s/Krishna Menon
Krishna Menon